Literature DB >> 2480183

Effect of procaine hydrochloride on the electrophoretic mobility of human red blood cells.

S O Sowemimo-Coker1, H J Meiselman.   

Abstract

The interaction of cationic anesthetics with biological membranes and the resulting alterations of membrane electrokinetic properties continue to be of current interest. The present study was designed to examine the effects of procaine hydrochloride (PRHCL) on the mobility of human red blood cells (RBC); electrophoretic measurements were made on RBC suspended in phosphate-buffered saline (PBS, pH = 5.0, 7.4, or 9.2), autologous plasma or 3 g% dextran T70/PBS (pH = 7.4), with PRHCL concentrations from 8 x 10(-6) to 8 x 10(-2) M. Low concentrations of PRHCL (8 x 10(-5)-8 x 10(-3) M) significantly (p less than 0.001) increased RBC mobility, with a maximal increase of 8.2% at 8 x 10(-4) M. Conversely, a higher PRHCL concentration (8 x 10(-2) M significantly (p less than 0.001) decreased RBC mobility. Both glutaraldehyde fixation and lipid extraction abolished any PRHCL-induced increase in RBC mobility; the observed increases in mobility for normal cells are, thus, consistent with a mechanism based on expansion of the RBC membrane glycocalyx. Microelectrophoretic methods were also used to study the effect of PRHCL (8 x 10(-4) and 8 x 10(-2) M) on RBC membrane calcium binding, with the results indicating that PRHCL competes with calcium for neuraminate binding sites. We conclude that the observed changes in RBC electrokinetic properties reflect incorporation of PRHCL into the RBC membrane; such changes may be of importance in modulating cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480183     DOI: 10.1007/bf02989686

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  24 in total

1.  The phospholipids of the erythrocyte 'ghosts' of various species.

Authors:  R M DAWSON; N HEMINGTON; D B LINDSAY
Journal:  Biochem J       Date:  1960-11       Impact factor: 3.857

2.  Calculation of the electrophoretic mobility of a particle bearing bound polyelectrolyte using the nonlinear poisson-boltzmann equation.

Authors:  K A Sharp; D E Brooks
Journal:  Biophys J       Date:  1985-04       Impact factor: 4.033

3.  Interaction of dibucaine and propranolol with phospholipid bilayer membranes-effect of alterations in fatty acyl composition.

Authors:  M A Singer
Journal:  Biochem Pharmacol       Date:  1977-01-01       Impact factor: 5.858

4.  Electrophoretic studies on human polymorphonuclear leukocytes and erythrocytes: the binding of calcium ions within the peripheral regions.

Authors:  G V Seaman; P S Vassar; M J Kendall
Journal:  Arch Biochem Biophys       Date:  1969-12       Impact factor: 4.013

5.  Electrophoretic mobility of human erythrocytes. On the applicability of the charged layer model.

Authors:  E Donath; A Voigt
Journal:  Biophys J       Date:  1986-02       Impact factor: 4.033

6.  Theory of the electrokinetic behavior of human erythrocytes.

Authors:  S Levine; M Levine; K A Sharp; D E Brooks
Journal:  Biophys J       Date:  1983-05       Impact factor: 4.033

7.  Platelet membrane alterations induced by the local anesthetic dibucaine.

Authors:  E I Peerschke
Journal:  Blood       Date:  1986-08       Impact factor: 22.113

8.  Effect of procaine HCLl on ATP: calcium-dependent alterations in red cell shape and deformability.

Authors:  J Palek; A Liu; D Liu; L M Snyder; N L Fortier; G Njoku; F Kiernan; D Funk; T Crusberg
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

9.  An experimental test of new theoretical models for the electrokinetic properties of biological membranes. The effect of UO2++ and tetracaine on the electrophoretic mobility of bilayer membranes and human erythrocytes.

Authors:  L Pasquale; A Winiski; C Oliva; G Vaio; S McLaughlin
Journal:  J Gen Physiol       Date:  1986-12       Impact factor: 4.086

10.  Influence of the ionic composition of fluid medium on red cell aggregation.

Authors:  K M Jan; S Chien
Journal:  J Gen Physiol       Date:  1973-05       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.